Mark W Tenforde1, Jessie Chung1, Emily R Smith1,2, H Keipp Talbot3, Christopher H Trabue4, Richard K Zimmerman5, Fernanda P Silveira5, Manjusha Gaglani6, Kempapura Murthy6, Arnold S Monto7, Emily T Martin7, Huong Q McLean8, Edward A Belongia8, Lisa A Jackson9, Michael L Jackson9, Jill M Ferdinands1, Brendan Flannery1, Manish M Patel1. 1. Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 2. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA. 3. Vanderbilt University Medical Center, Nashville, Tennessee, USA. 4. University of Tennessee Health Science Center, Saint Thomas Health, Nashville, Tennessee, USA. 5. University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. 6. Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA. 7. University of Michigan School of Public Health, Ann Arbor, Michigan, USA. 8. Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA. 9. Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Abstract
BACKGROUND: Demonstration of influenza vaccine effectiveness (VE) against hospitalized illness in addition to milder outpatient illness may strengthen vaccination messaging. Our objective was to compare patient characteristics and VE between United States (US) inpatient and outpatient VE networks. METHODS: We tested adults with acute respiratory illness (ARI) for influenza within 1 outpatient-based and 1 hospital-based VE network from 2015 through 2018. We compared age, sex, and high-risk conditions. The test-negative design was used to compare vaccination odds in influenza-positive cases vs influenza-negative controls. We estimated VE using logistic regression adjusting for site, age, sex, race/ethnicity, peak influenza activity, time to testing from, season (overall VE), and underlying conditions. VE differences (ΔVE) were assessed with 95% confidence intervals (CIs) determined through bootstrapping with significance defined as excluding the null. RESULTS: The networks enrolled 14 573 (4144 influenza-positive) outpatients and 6769 (1452 influenza-positive) inpatients. Inpatients were older (median, 62 years vs 49 years) and had more high-risk conditions (median, 4 vs 1). Overall VE across seasons was 31% (95% CI, 26%-37%) among outpatients and 36% (95% CI, 27%-44%) among inpatients. Strain-specific VE (95% CI) among outpatients vs inpatients was 37% (25%-47%) vs 53% (37%-64%) against H1N1pdm09; 19% (9%-27%) vs 23% (8%-35%) against H3N2; and 46% (38%-53%) vs 46% (31%-58%) against B viruses. ΔVE was not significant for any comparison across all sites. CONCLUSIONS: Inpatients and outpatients with ARI represent distinct populations. Despite comparatively poor health among inpatients, influenza vaccination was effective in preventing influenza-associated hospitalizations. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
BACKGROUND: Demonstration of influenza vaccine effectiveness (VE) against hospitalized illness in addition to milder outpatient illness may strengthen vaccination messaging. Our objective was to compare patient characteristics and VE between United States (US) inpatient and outpatient VE networks. METHODS: We tested adults with acute respiratory illness (ARI) for influenza within 1 outpatient-based and 1 hospital-based VE network from 2015 through 2018. We compared age, sex, and high-risk conditions. The test-negative design was used to compare vaccination odds in influenza-positive cases vs influenza-negative controls. We estimated VE using logistic regression adjusting for site, age, sex, race/ethnicity, peak influenza activity, time to testing from, season (overall VE), and underlying conditions. VE differences (ΔVE) were assessed with 95% confidence intervals (CIs) determined through bootstrapping with significance defined as excluding the null. RESULTS: The networks enrolled 14 573 (4144 influenza-positive) outpatients and 6769 (1452 influenza-positive) inpatients. Inpatients were older (median, 62 years vs 49 years) and had more high-risk conditions (median, 4 vs 1). Overall VE across seasons was 31% (95% CI, 26%-37%) among outpatients and 36% (95% CI, 27%-44%) among inpatients. Strain-specific VE (95% CI) among outpatients vs inpatients was 37% (25%-47%) vs 53% (37%-64%) against H1N1pdm09; 19% (9%-27%) vs 23% (8%-35%) against H3N2; and 46% (38%-53%) vs 46% (31%-58%) against B viruses. ΔVE was not significant for any comparison across all sites. CONCLUSIONS: Inpatients and outpatients with ARI represent distinct populations. Despite comparatively poor health among inpatients, influenza vaccination was effective in preventing influenza-associated hospitalizations. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Authors: Guillermo M Ruiz-Palacios; Irene Pérez-Schael; F Raúl Velázquez; Hector Abate; Thomas Breuer; SueAnn Costa Clemens; Brigitte Cheuvart; Felix Espinoza; Paul Gillard; Bruce L Innis; Yolanda Cervantes; Alexandre C Linhares; Pío López; Mercedes Macías-Parra; Eduardo Ortega-Barría; Vesta Richardson; Doris Maribel Rivera-Medina; Luis Rivera; Belén Salinas; Noris Pavía-Ruz; Jorge Salmerón; Ricardo Rüttimann; Juan Carlos Tinoco; Pilar Rubio; Ernesto Nuñez; M Lourdes Guerrero; Juan Pablo Yarzábal; Silvia Damaso; Nadia Tornieporth; Xavier Sáez-Llorens; Rodrigo F Vergara; Timo Vesikari; Alain Bouckenooghe; Ralf Clemens; Béatrice De Vos; Miguel O'Ryan Journal: N Engl J Med Date: 2006-01-05 Impact factor: 91.245
Authors: Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Don Middleton; Arnold S Monto; Kempapura Murthy; Fernanda P Silveira; H Keipp Talbot; Richard Zimmerman; Elif Alyanak; Courtney Strickland; Sarah Spencer; Alicia M Fry Journal: J Infect Dis Date: 2019-09-13 Impact factor: 5.226
Authors: Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean Journal: Lancet Infect Dis Date: 2016-04-06 Impact factor: 25.071
Authors: Robertus van Aalst; Stefan Gravenstein; Vincent Mor; Salaheddin M Mahmud; Jan Wilschut; Maarten Postma; Ayman Chit Journal: Vaccine Date: 2019-10-09 Impact factor: 3.641
Authors: Melissa K Andrew; Vivek Shinde; Lingyun Ye; Todd Hatchette; François Haguinet; Gael Dos Santos; Janet E McElhaney; Ardith Ambrose; Guy Boivin; William Bowie; Ayman Chit; May ElSherif; Karen Green; Scott Halperin; Barbara Ibarguchi; Jennie Johnstone; Kevin Katz; Joanne Langley; Jason Leblanc; Mark Loeb; Donna MacKinnon-Cameron; Anne McCarthy; Allison McGeer; Jeff Powis; David Richardson; Makeda Semret; Grant Stiver; Sylvie Trottier; Louis Valiquette; Duncan Webster; Shelly A McNeil Journal: J Infect Dis Date: 2017-08-15 Impact factor: 5.226
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Tiffany A Walker; Ben Waite; Mark G Thompson; Colin McArthur; Conroy Wong; Michael G Baker; Tim Wood; Jennifer Haubrock; Sally Roberts; Diane K Gross; Q Sue Huang; E Claire Newbern Journal: J Infect Dis Date: 2020-01-02 Impact factor: 5.226
Authors: Carrie Reed; Sandra S Chaves; Alejandro Perez; Tiffany D'Mello; Pamala Daily Kirley; Deborah Aragon; James I Meek; Monica M Farley; Patricia Ryan; Ruth Lynfield; Craig A Morin; Emily B Hancock; Nancy M Bennett; Shelley M Zansky; Ann Thomas; Mary Louise Lindegren; William Schaffner; Lyn Finelli Journal: Clin Infect Dis Date: 2014-04-29 Impact factor: 9.079
Authors: Deshayne B Fell; Eduardo Azziz-Baumgartner; Michael G Baker; Maneesh Batra; Julien Beauté; Philippe Beutels; Niranjan Bhat; Zulfiqar A Bhutta; Cheryl Cohen; Bremen De Mucio; Bradford D Gessner; Michael G Gravett; Mark A Katz; Marian Knight; Vernon J Lee; Mark Loeb; Johannes M Luteijn; Helen Marshall; Harish Nair; Kevin Pottie; Rehana A Salam; David A Savitz; Suzanne J Serruya; Becky Skidmore; Justin R Ortiz Journal: Vaccine Date: 2017-09-01 Impact factor: 3.641
Authors: Katherine Adams; Mark W Tenforde; Shreya Chodisetty; Benjamin Lee; Eric J Chow; Wesley H Self; Manish M Patel Journal: Hum Vaccin Immunother Date: 2021-11-10 Impact factor: 3.452
Authors: Carlos G Grijalva; Leora R Feldstein; H Keipp Talbot; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Jonathan D Casey; Heidi L Erickson; Matthew C Exline; D Clark Files; Kevin W Gibbs; Adit A Ginde; Michelle N Gong; Natasha Halasa; Akram Khan; Christopher J Lindsell; Samuel K Nwosu; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay S Steingrub; William B Stubblefield; Mark W Tenforde; Manish M Patel; Wesley H Self Journal: Clin Infect Dis Date: 2021-10-20 Impact factor: 9.079
Authors: Jill M Ferdinands; Manjusha Gaglani; Shekhar Ghamande; Emily T Martin; Donald Middleton; Arnold S Monto; Fernanda Silveira; Helen K Talbot; Richard Zimmerman; Emily R Smith; Manish Patel Journal: J Infect Dis Date: 2021-07-02 Impact factor: 5.226
Authors: Shekhar Ghamande; Courtney Shaver; Kempapura Murthy; Chandni Raiyani; Heath D White; Tasnim Lat; Alejandro C Arroliga; Dayna Wyatt; H Keipp Talbot; Emily T Martin; Arnold S Monto; Richard K Zimmerman; Donald B Middleton; Fernanda P Silveira; Jill M Ferdinands; Manish M Patel; Manjusha Gaglani Journal: Clin Infect Dis Date: 2022-04-28 Impact factor: 20.999
Authors: Mark W Tenforde; Erica Billig Rose; Christopher J Lindsell; Nathan I Shapiro; D Clark Files; Kevin W Gibbs; Matthew E Prekker; Jay S Steingrub; Howard A Smithline; Michelle N Gong; Michael S Aboodi; Matthew C Exline; Daniel J Henning; Jennifer G Wilson; Akram Khan; Nida Qadir; William B Stubblefield; Manish M Patel; Wesley H Self; Leora R Feldstein Journal: MMWR Morb Mortal Wkly Rep Date: 2020-07-03 Impact factor: 17.586
Authors: Kailey Hughes; Donald B Middleton; Mary Patricia Nowalk; Goundappa K Balasubramani; Emily T Martin; Manjusha Gaglani; H Keipp Talbot; Manish M Patel; Jill M Ferdinands; Richard K Zimmerman; Fernanda P Silveira Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: H Keipp Talbot; Emily T Martin; Manjusha Gaglani; Donald B Middleton; Shekhar Ghamande; Fernanda P Silveira; Kempapura Murthy; Richard K Zimmerman; Christopher H Trabue; Samantha M Olson; Joshua G Petrie; Jill M Ferdinands; Manish M Patel; Arnold S Monto Journal: Clin Infect Dis Date: 2021-12-16 Impact factor: 9.079
Authors: Mark W Tenforde; Rebecca J Garten Kondor; Jessie R Chung; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Arundhati Rao; Sara S Kim; Thomas J Stark; John R Barnes; David E Wentworth; Manish M Patel; Brendan Flannery Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 20.999